Neurogene (NGNE) Enterprise Value (2018 - 2025)
Neurogene's Enterprise Value history spans 6 years, with the latest figure at -$269.0 million for Q4 2025.
- For Q4 2025, Enterprise Value rose 13.89% year-over-year to -$269.0 million; the TTM value through Dec 2025 reached -$269.0 million, up 13.89%, while the annual FY2025 figure was -$269.0 million, 13.89% up from the prior year.
- Enterprise Value reached -$269.0 million in Q4 2025 per NGNE's latest filing, down from -$265.4 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$78.5 million in Q3 2023 to a low of -$312.4 million in Q4 2024.
- Average Enterprise Value over 3 years is -$193.1 million, with a median of -$183.3 million recorded in 2023.
- Peak YoY movement for Enterprise Value: crashed 103.19% in 2024, then increased 13.89% in 2025.
- A 3-year view of Enterprise Value shows it stood at -$197.2 million in 2023, then crashed by 58.45% to -$312.4 million in 2024, then rose by 13.89% to -$269.0 million in 2025.
- Per Business Quant, the three most recent readings for NGNE's Enterprise Value are -$269.0 million (Q4 2025), -$265.4 million (Q3 2025), and -$274.5 million (Q2 2025).